TRxADE HEALTH, Inc. / Fundamentals

    Income statement

    Net revenue
    €110.00K
    Cost of goods sold
    €96.54K
    Gross profit
    €13.46K
    SG&A expenses
    €6.73M
    R&D expenses
    €3.09M
    EBITDA
    €5.88M
    D&A
    -€14.30K
    EBIT
    -€18.51M
    Interest expenses
    -€2.37M
    EBT
    €6.93M
    Tax expenses
    -€1.09M
    Net income
    €8.20M

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    €8.24M
    Changes in working capital
    €2.29M
    Operating cash flow
    -€10.57M
    Capex
    €0.00
    Other investing cash flow
    €103.80K
    Net investing cash flow
    €2.25M
    Total cash dividends paid
    -€1.88M
    Issuance of common stock
    €4.15M
    Debt repayment
    €0.00
    Other financing cash flow
    €1.84M
    Net financing cash flow
    €4.82M
    Foreign exchange effects
    €0.00
    Net change in cash
    -€6.61M
    Cash at end of period
    €13.21K
    Free cash flow
    -€10.57M

    Balance sheet

    Cash and cash equivalents
    €13.21K
    Cash and short-term investments
    €13.21K
    Total receivables
    €53.63K
    Inventory
    €0.00
    Other current assets
    €668.15K
    Total current assets
    €734.98K
    Property, plant & equipment
    €39.74K
    Goodwill
    €18.34M
    Intangible assets
    €65.55M
    Long-term investments
    €0.00
    Other non-current assets
    €4.36M
    Total non-current assets
    €88.75M
    Total assets
    €89.49M
    Accounts payable
    €2.69M
    Short-term debt
    €1.74M
    Other current liabilities
    €2.17M
    Total current liabilities
    €6.60M
    Long-term debt
    €1.36M
    Deferred tax liabilities
    €11.60M
    Other non-current liabilities
    €3.12M
    Total non-current liabilities
    €16.08M
    Total liabilities
    €22.68M
    Common stock
    €138.14
    Retained earnings
    -€41.89M
    Other equity
    €0.00
    Total equity
    €66.80M
    Total liabilities and shareholders' equity
    €89.49M

    Company information

    Market capitalization
    €11.33M
    Employees
    8
    Enterprise Value
    €14.53M

    Company ratios

    Gross margin
    12.2% Much better than peer group: -27.9%
    EBITDA margin
    5,345.7% Much better than peer group: -4,301.6%
    EBIT margin
    -16,826.0% Much worse than peer group: -3,396.9%
    EBT margin
    6,300.4% Much better than peer group: -15,379.6%
    Net margin
    7,453.1% Much better than peer group: -15,506.4%
    ROE
    12.3% Much better than peer group: -20.2%
    ROA
    9.2% Much better than peer group: -10,555.0%
    Asset turnover
    0.1% Much worse than peer group: 1,230.3%
    FCF margin
    -9,607.7% Much worse than peer group: -5,980.3%
    FCF yield
    -93.3%
    Efficiency ratio
    -5,245.7%
    Net sales per employee
    €13.75K
    Net income per employee
    €1.02M

    Notifications